There is a newer version of this record available.

Report Open Access

Statistical review of A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 by B. Cao et al

Gates, Simon; Emsley, Richard; Dahly, Darren


DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="DOI">10.5281/zenodo.3746512</identifier>
  <creators>
    <creator>
      <creatorName>Gates, Simon</creatorName>
      <givenName>Simon</givenName>
      <familyName>Gates</familyName>
      <affiliation>Professor of Biostatistics and Clinical Trials, Cancer Research UK Clinical Trials Unit, University of Birmingham, UK</affiliation>
    </creator>
    <creator>
      <creatorName>Emsley, Richard</creatorName>
      <givenName>Richard</givenName>
      <familyName>Emsley</familyName>
      <affiliation>NIHR Research Professor &amp; Professor of Medical Statistics and Trials Methodology, Department of Biostatistics and Health Informatics, King's College London, UK</affiliation>
    </creator>
    <creator>
      <creatorName>Dahly, Darren</creatorName>
      <givenName>Darren</givenName>
      <familyName>Dahly</familyName>
      <affiliation>Principal Statistician, HRB Clinical Research Facility - Cork. HRB Trials Methodology Research Network. Senior Lecturer in Patient Focused Research Methods, University College Cork School of Public Health</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Statistical review of A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 by B. Cao et al</title>
  </titles>
  <publisher>Zenodo</publisher>
  <publicationYear>2020</publicationYear>
  <subjects>
    <subject>COVID-19</subject>
    <subject>clinical trials</subject>
    <subject>RCTs</subject>
    <subject>Lopinavir</subject>
    <subject>Ritonavir</subject>
  </subjects>
  <dates>
    <date dateType="Issued">2020-04-09</date>
  </dates>
  <language>en</language>
  <resourceType resourceTypeGeneral="Text">Report</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://zenodo.org/record/3746512</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.3746511</relatedIdentifier>
    <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/covid-19-tx-rct-stats-review</relatedIdentifier>
    <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://zenodo.org/communities/zenodo</relatedIdentifier>
  </relatedIdentifiers>
  <version>1.0</version>
  <rightsList>
    <rights rightsURI="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">&lt;p&gt;The following review has been prepared in collaboration with members of the MRC-NIHR Trials Methodology Research Partnership. The reviewers named above, and other, unnamed discussants of the paper, are all qualified statisticians with experience in clinical&amp;nbsp; trials. Our objective is to provide a rapid review of publications, preprints and protocols from clinical trials of COVID-19 treatments,&amp;nbsp; independent of journal specific review processes. We aim to provide timely, constructive, focused, clear advice aimed at improving both the research outputs under review, as well as future studies. Given our collective expertise (clinical trial statistics) our reviews&amp;nbsp; focus on the designs of the trials and other statistical content (methods, presentation and accuracy of results, inferences). Here we review &lt;em&gt;A Trial of Lopinavir&amp;ndash;Ritonavir in Adults Hospitalized with Severe Covid-19&lt;/em&gt;, by B.Cao &lt;em&gt;et al&lt;/em&gt;, published in the New England Journal of Medicine on 18 March 2020. This was one of the first randomised controlled trials of treatments for COVID-19 to be published, and the first in a high-profile medical journal.&lt;/p&gt;</description>
  </descriptions>
</resource>
1,297
733
views
downloads
All versions This version
Views 1,297981
Downloads 733565
Data volume 109.3 MB84.1 MB
Unique views 1,112870
Unique downloads 651519

Share

Cite as